I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| hepatocyte | 5 studies | 77% ± 19% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hepatocyte | 5 studies | 77% ± 19% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 4 studies | 36% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 44252.36 | 226 / 226 | 81% | 226.57 | 327 / 406 |
| kidney | 100% | 104.52 | 89 / 89 | 25% | 0.78 | 223 / 901 |
| adrenal gland | 82% | 10.47 | 212 / 258 | 3% | 0.11 | 7 / 230 |
| lung | 71% | 6.80 | 409 / 578 | 4% | 0.07 | 44 / 1155 |
| skin | 74% | 11.13 | 1337 / 1809 | 1% | 0.04 | 3 / 472 |
| adipose | 74% | 16.74 | 885 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 58% | 8.00 | 842 / 1445 | 14% | 0.48 | 26 / 183 |
| thymus | 65% | 5.49 | 424 / 653 | 0% | 0.00 | 1 / 605 |
| bladder | 62% | 4.14 | 13 / 21 | 3% | 0.06 | 15 / 504 |
| spleen | 65% | 103.03 | 156 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 61% | 5.47 | 809 / 1335 | 0% | 0 | 0 / 0 |
| breast | 54% | 8.35 | 247 / 459 | 0% | 0.22 | 3 / 1118 |
| stomach | 43% | 3.18 | 154 / 359 | 3% | 0.04 | 8 / 286 |
| intestine | 44% | 3.89 | 421 / 966 | 1% | 1.76 | 5 / 527 |
| pancreas | 41% | 3.31 | 134 / 328 | 2% | 0.03 | 4 / 178 |
| prostate | 42% | 2.87 | 102 / 245 | 0% | 0.00 | 2 / 502 |
| uterus | 39% | 2.98 | 67 / 170 | 3% | 0.06 | 12 / 459 |
| ovary | 42% | 2.89 | 75 / 180 | 0% | 0 | 0 / 430 |
| peripheral blood | 33% | 13.54 | 303 / 929 | 0% | 0 | 0 / 0 |
| heart | 32% | 3.96 | 279 / 861 | 0% | 0 | 0 / 0 |
| muscle | 28% | 1.97 | 223 / 803 | 0% | 0 | 0 / 0 |
| brain | 26% | 1.76 | 674 / 2642 | 0% | 0.01 | 3 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.25 | 5 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051260 | Biological process | protein homooligomerization |
| GO_0001906 | Biological process | cell killing |
| GO_0031640 | Biological process | killing of cells of another organism |
| GO_0050778 | Biological process | positive regulation of immune response |
| GO_0006957 | Biological process | complement activation, alternative pathway |
| GO_0006958 | Biological process | complement activation, classical pathway |
| GO_0006956 | Biological process | complement activation |
| GO_0005615 | Cellular component | extracellular space |
| GO_0072562 | Cellular component | blood microparticle |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005579 | Cellular component | membrane attack complex |
| GO_0044218 | Cellular component | other organism cell membrane |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | C9 |
| Protein name | Complement component C9 [Cleaved into: Complement component C9a; Complement component C9b] Complement component C9 Complement component 9 |
| Synonyms | |
| Description | FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells . C9 is the pore-forming subunit of the MAC . . |
| Accessions | ENST00000263408.5 A0A8Q3SI37 ENST00000695881.1 A0A8Q3SI95 A0A8Q3SI39 ENST00000695880.1 ENST00000509186.6 P02748 Q9UGI4 |
